Accenture Expands SAP Capabilities In Nordics Through Einr AS Acquisition
Accenture PLC (NYSE:ACN) announced the acquisition of a business consulting company, Einr AS, in Norway for undisclosed terms. Einr AS…
What’s Driving Today’s Communication Services Sector (XLC) Rally? 5 Stocks To Watch And What’s Next
The Communication Services Select Sector SPDR Fund (ARCA: XLC) rallied nearly 6% on Thursday, on track to post its second-best performing session so far in 2023.
Analyst Impressed With CONMED’s Upbeat Q1 Performance and Raised Guidance, Bullish On Organic Growth
CONMED Corporation (NYSE: CNMD) shares are trading higher after the company reported better-than-expected
Newmont Q1 Earnings Miss On Production Decline, Says On Track To Achieve 2023 Guidance
Newmont Corp (NYSE:NEM) reported Q1 2023 revenues of $2.68 billion, down 11% Y/Y, missing the consensus of $3.60 billion. Gold…
FDA Casts Doubt on Merck/AstraZeneca’s Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
The FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss the supplemental new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone for metastatic castration-resistant prostate cancer (mCRPC).
Deutsche Bank Q1 Result: Strongest Quarterly Revenues Since 2016, Announces Efficiency Improvement Strategy, May Commence Buyback in H2 2023
Deutsche Bank AG (NYSE:DB) reported Q1 2023 revenue growth of 5% to €7.7 billion, the highest since 2016. Revenue…
Alnylam – Regeneron Partnered Alzheimer’s Candidate’s Initial Data Sounds Promising, Analyst Says
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) and its partner Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down
Bristol Myers Squibb & Co (NYSE:BMY) said that its Q1 sales of $11.34 billion fell 3% Y/Y due to Revlimid generic…
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
French drugmaker Sanofi SA (NASDAQ: SNY) reported an 8.7% Y/Y (+9.3% on constant currency) rise in
Eli Lilly Highlights Weight Loss Data For Tirzepatide In Diabetes Patients
Eli Lilly And Co's (NYSE: LLY) tirzepatide (10 mg and 15 mg)